Xconomy

JUNE 14, 2018

New immunotherapy approaches to cancer treatment, and the CRISPR technology for editing genetic material in cells, are among the most sophisticated research strategies scientists are using in their quest to defeat disease.

Research 74

Research Software Engineering Software Technology 74

Xconomy

FEBRUARY 15, 2017

The final numbers on 2016 fintech funding deals are in from New York-based research firm and investment database CB Insights, and venture capitalists seem to be cooling on the industry. billion in venture capital across 836 investments last year. billion.

Venture Capital 59

Venture Capital Report Research Activity 59

Xconomy

SEPTEMBER 5, 2017

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland.

Invest 88

Invest Funding San Diego Venture Capital 88

Xconomy

OCTOBER 13, 2017

The idea in 2011 was to create a space at what was then Johnson & Johnson’s pharmaceutical research and development facility in San Diego for an “innovation center,” a place where 18 to 20 life sciences startups could incubate, replete with lab space and equipment.

San Diego 75

San Diego Incubator Screening Research 75

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Xconomy

MAY 31, 2017

One of them is a San Antonio researcher hoping to use gene therapy—a potentially one-time, long lasting treatment—to do the trick. When cells in the pancreas , known as beta cells, either get destroyed by the immune system.

Research 58

Research Funding San Diego Company 58

Xconomy

DECEMBER 7, 2018

The biggest yearly meeting for blood disease research has come and gone, and yet the stories to come out of the American Society of Hematology’s gathering in San Diego represent just a fraction of what happened in biopharma this week.

San Diego 70

San Diego Research Product Venture Capital 70

Xconomy

DECEMBER 26, 2018

The sector saw more big venture capital deals and acquisitions , while researchers kept plugging away on technology advances. It was an eventful year for the artificial intelligence industry. Meanwhile, A.I. developers continued to grapple with issues around transparency, trust, and ethics.

Artificial Inteligence 94

Artificial Inteligence Venture Capital Research Acquisition 94

Xconomy

MARCH 22, 2018

For the first 50 years of its existence, Bose Corporation invested primarily in in-house research and development to produce its lineup of high-end headphones, speakers, and other audio technologies.

Venture Capital 70

Venture Capital Patents Research Invest 70

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Both Sides of the Table

APRIL 13, 2011

I owe ya’ a 20 minute call (or in person next time I’m in San Diego). Brad on blogging. How did you start blogging? “My Yeah, that was when I changed for me…” “…there was so much positive feedback on demystifying this one element of venture capital. Brad’s start in Venture Capital.

Venture Capital 288

Venture Capital Startup Technical Review Software Review 288

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

Both Sides of the Table

JUNE 8, 2014

Changes in the Software World & in Venture Capital. But notably you had the following changes: Horizontally scalable computing & storage systems, which meant you required less capital up front for hardware. I’ve blogged about this before and provide a lot more details in these posts: 1. Venture Capital.

Startup 390

Startup Venture Capital Capital Funding 390

Xconomy

JUNE 19, 2019

San Diego’s Element Biosciences said Tuesday that it had secured a Series A round led by Foresite Capital, a healthcare and life sciences venture capital firm based in San Francisco, and Silicon Valley’s Venrock. Molly He, Element’s CEO and co-founder, is a venture partner at Foresite.

Tool 67

Tool Develop Development Venture Capital 67

Xconomy

JUNE 26, 2018

But that is starting to change, as Asian cities—particularly in China—are snapping up more tech venture capital funding and exits, according to a new report from CB Insights. But Beijing and Shanghai startups appear to be working to keep pace, reeling in $72.

Startup 84

Startup Report Venture Capital Research 84

Xconomy

MARCH 13, 2018

Crinetics Pharmaceuticals , a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 Two new investors, RA Capital and OrbiMed, joined the round, along with existing investors 5AM Ventures, Versant Ventures, and Vivo Capital.

San Diego 49

San Diego Research Funding Capital 49

Xconomy

JUNE 22, 2016

Agtech investment firm Finistere Ventures; private equity firm Cloud Break Advisors; and Israeli venture capital firm OurCrowd contributed to the new accelerator. Radicle representatives plan to discuss their plans for the accelerator during AgTech Week 2016 , an ag investment conference being held in San Francisco this week.

Funding 68

Funding Research San Diego Incubator 68

Xconomy

NOVEMBER 8, 2017

Peter Lee is the Microsoft Research executive in charge of the NExT initiative—an effort quietly begun in 2014 by CEO Satya Nadella and Harry Shum, head of the company’s A.I. division, to convert select projects from the company’s global research apparatus into business opportunities.

Artificial Inteligence 75

Artificial Inteligence Research Venture Capital Capital 75

Xconomy

SEPTEMBER 2, 2020

Research has yielded a crop of gastrointestinal disorder drug. Seattle-based Lumen turns spirulina into tiny factories that churn out therapeutic antibodies. Finrow says the Lumen technology overcomes many of the challenges of working with cyanobacteria. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 120

Research Startup Technology San Diego 120

Xconomy

MARCH 20, 2018

We’re recapping them very quickly here, and adding two reaction quotes we received from Carrie Morton, deputy director of the University of Michigan’s Mcity research facility and test bed, and Shahin Farshchi, a partner at Lux Capital, a Silicon Valley venture capital firm that has a number of investments in mobility companies.

Venture Capital 75

Venture Capital Research Mobile Capital 75

Xconomy

SEPTEMBER 23, 2019

Ivan Liachko turned postdoctoral research at the University of Washington into a company whose genomics tools are now found in laboratories researching human, animal, and plant health. His firm, Phase Genomics was one of the first startups to come out of UW’s genome sciences department. Some technologies developed in UW labs.

Incubator 111

Incubator Research Tool Startup 111

Xconomy

JUNE 28, 2018

The Series D round included investments from previous BitSight backers Menlo Ventures, GGV Capital, and Singtel Innov8. The new funding brings BitSight’s total venture capital haul to $155. Read more » Reprints | Share:

Venture Capital 55

Venture Capital Equity Research Capital 55

Xconomy

APRIL 23, 2019

We’ll tackle big trends, challenges, and opportunities in areas like venture capital, software, genomics, digital medicine, education, and diversity. This is our most special event of the year—the eighth year we’ve held it—and it’s limited to about 100 VIP guests.

Venture Capital 90

Venture Capital Google Conference Education 90

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. So far this year four privately held companies have made the transition to trading on the public markets.

Westlake Village 109

Westlake Village Class Research Capital 109

Xconomy

MAY 15, 2017

San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). Founding CEO Kevin Lustig said Scientist.com will use the additional cash to expand its operations. Lustig argued.

Outsource 79

Outsource Marketing Research Web 79

Xconomy

JANUARY 13, 2019

trillion annually, according to IHL, a Tennessee firm that specializes in retail and hospitality research. “Something like one out of eight or 10 items is typically not in stock.” Inaccurate inventory costs retailers $1.1 Pensa, an Austin startup. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 109

Research Sales Startup Artificial Inteligence 109

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund.

San Diego 40

San Diego Avalon Research Examples 40

Xconomy

JUNE 26, 2018

The practice of encoding data in DNA molecules could be inching closer to graduating from research labs to finding practical commercial use. Some academic researchers and business leaders think that the solution could be to house information in lab-made DNA molecules instead of silicon.

Research 79

Research San Diego UCLA Venture Capital 79

Xconomy

SEPTEMBER 6, 2016

After signaling that it plans to operate drones via cellular technologies, San Diego-based Qualcomm says today it is working with AT&T to use commercial wireless networks for test flights beyond an operator’s visual line of sight.

Networking 40

Networking San Diego Technology Research 40

Xconomy

DECEMBER 10, 2018

San Antonio — When it comes to medical technology, what’s good for the military isn’t always good for the private sector.

Research 111

Research Tool Help Technology 111

Xconomy

MAY 29, 2020

Today a virtual version of the ASCO conference, the cancer field’s largest, kicks off, with oncologists and others tuning in from throughout the country and around the world to check out the latest in cancer research.

Screening 67

Screening Conference Research Course 67

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

MARCH 2, 2020

With one investigational cancer drug in Phase 1 testing and a second one approaching the clinic, ORIC Pharmaceuticals is looking to tap the public markets for funds to finance that research.

Study 90

Study Research Funding Marketing 90

Xconomy

JUNE 13, 2019

The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. One, headed for Phase 2 testing by next year, is being developed for mood or anxiety disorders.

Tool 78

Tool Study Research Startup 78

Xconomy

SEPTEMBER 19, 2016

from San Francisco, San Diego, and Seattle on the west coast to Boston, New York, and Research Triangle Park out east. Alexandria already has its own venture arm, Alexandria Venture Investments, and is a co-founder of Accelerator Corp., First, the real estate.

Venture Capital 40

Venture Capital Startup San Diego Class 40

Xconomy

AUGUST 7, 2020

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs are testing compounds, previously intended for a wide range of indications, as potential COVID-19 treatments. billion merger in the digital health sector.

Research 80

Research Develop Development Edmunds 80

Xconomy

NOVEMBER 15, 2018

A growing number of startups are trying to encourage people to share genomic and other health data for research purposes by offering them some form of compensation. million from Khosla Ventures, Arch Venture Partners, and several other investors.

Startup 104

Startup Competition Research San Diego 104